CONTENT

This domain investors.edgetherapeutics.com states the following, "Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions." Our analyzers observed that the website said " Our lead product candidate, can fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm." The Website also stated " Data as of March 14, 2018 400 pm ET." The website's header had NASDAQ as the most important keyword.